{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:43:47Z","timestamp":1791290627216,"version":"4.3.0"},"reference-count":46,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,2,2]]},"DOI":"10.3233\/jad-150487","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T07:27:44Z","timestamp":1454916464000},"page":"779-789","source":"Crossref","is-referenced-by-count":30,"title":["Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention"],"prefix":"10.1177","volume":"50","author":[{"given":"Daniel A.","family":"Nation","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-150487_ref1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"10.3233\/JAD-150487_ref2","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/01.wnl.0000436935.47657.78","article-title":"Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults","volume":"81","author":"Nation","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-150487_ref3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamaneurol.2014.4477","article-title":"Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults","volume":"72","author":"Nation","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-150487_ref4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3233\/JAD-2012-120922","article-title":"Preventing Alzheimer\u2019s disease by targeting vascular risk factors: Hope and gap","volume":"32","author":"Qiu","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150487_ref5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150487_ref6","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/HYPERTENSIONAHA.110.165142","article-title":"Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia","volume":"57","author":"Staessen","year":"2011","journal-title":"Hypertension"},{"key":"10.3233\/JAD-150487_ref7","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"10.3233\/JAD-150487_ref8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/HJH.0000000000000086","article-title":"Angiotension receptor blockers reduce the risk of dementia","volume":"32","author":"Chiu","year":"2014","journal-title":"J Hypertens"},{"key":"10.3233\/JAD-150487_ref9","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/HJH.0b013e328301a280","article-title":"Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: Primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study","volume":"26","author":"Hanon","year":"2008","journal-title":"J Hypertens"},{"key":"10.3233\/JAD-150487_ref10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2011-110347","article-title":"Associations of anti-hypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias","volume":"26","author":"Davies","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150487_ref11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1447-0594.2011.00746.x","article-title":"Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer\u2019s disease","volume":"12","author":"Kume","year":"2012","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-150487_ref12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinternmed.2011.1391","article-title":"Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: A double-blind randomized clinical trial","volume":"172","author":"Hajjar","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.3233\/JAD-150487_ref13","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","article-title":"Antihypertensive classes, cognitive decline and incidence of dementia: A network meta-analysis","volume":"31","author":"Levi Marpillat","year":"2013","journal-title":"J Hypertens"},{"key":"10.3233\/JAD-150487_ref14","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-150487_ref15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2014.03.030","article-title":"Differential effects of angiotensin II receptor blockers on Abeta generation","volume":"567","author":"Liu","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-150487_ref16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbrc.2008.08.032","article-title":"Telmisartan prevented cognitive decline partly due to PPAR-gamma activation","volume":"375","author":"Mogi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-150487_ref17","doi-asserted-by":"crossref","first-page":"e16037","DOI":"10.1371\/journal.pone.0016037","article-title":"Central angiotensin II stimulation promotes beta amyloid production in Sprague Dawley rats","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-150487_ref18","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1016\/j.febslet.2012.09.004","article-title":"Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains","volume":"586","author":"Tian","year":"2012","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-150487_ref19","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archneurol.2012.1010","article-title":"Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series","volume":"69","author":"Hajjar","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-150487_ref20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2990.2007.00885.x","article-title":"Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer\u2019s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy","volume":"34","author":"Miners","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-150487_ref21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fnagi.2014.00238","article-title":"Abeta degradation or cerebral perfusion? Divergent effects of multifunctional enzymes","volume":"6","author":"Miners","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-150487_ref22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JAD-131496","article-title":"Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy","volume":"44","author":"Jochemsen","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150487_ref23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/alzrt257","article-title":"The association of angiotensin-converting enzyme with biomarkers for Alzheimer\u2019s disease","volume":"6","author":"Jochemsen","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-150487_ref24","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1517\/13543784.2013.812631","article-title":"Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer\u2019s disease","volume":"22","author":"Ashby","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.3233\/JAD-150487_ref25","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"key":"10.3233\/JAD-150487_ref26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/01.wnl.0000435301.64776.37","article-title":"Pulse wave velocity is associated with beta-amyloid deposition in the brains of very elderly adults","volume":"81","author":"Hughes","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-150487_ref27","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.3233\/JAD-150487_ref28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): Clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-150487_ref29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150487_ref30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3233\/JAD-2010-091699","article-title":"Arterial spin labeling blood flow MRI: Its role in the early characterization of Alzheimer\u2019s disease","volume":"20","author":"Alsop","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150487_ref31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.STR.25.1.40","article-title":"Stroke risk profile: Adjustment for antihypertensive medication. The Framingham Study","volume":"25","author":"D\u2019Agostino","year":"1994","journal-title":"Stroke"},{"key":"10.3233\/JAD-150487_ref32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jamaneurol.2013.1342","article-title":"Risk factors for beta-amyloid deposition in healthy aging: Vascular and genetic effects","volume":"70","author":"Rodrigue","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-150487_ref33","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1212\/WNL.0b013e318238eec1","article-title":"Alzheimer disease biomarkers are associated with body mass index","volume":"77","author":"Vidoni","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-150487_ref34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.52.3.547","article-title":"CSF beta-amyloid, cognition, and APOE genotype in Alzheimer\u2019s disease","volume":"52","author":"Samuels","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-150487_ref35","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.wnl.0000345881.82856.d5","article-title":"Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons","volume":"72","author":"Hoffman","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-150487_ref36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.expneurol.2009.09.012","article-title":"The brain RAS and Alzheimer\u2019s disease","volume":"223","author":"Wright","year":"2010","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-150487_ref37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.3233\/JAD-150487_ref38","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/hr.2009.110","article-title":"Effects of angiotensin II receptor blockers on dementia","volume":"32","author":"Mogi","year":"2009","journal-title":"Hypertens Res"},{"key":"10.3233\/JAD-150487_ref39","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","article-title":"Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice","volume":"128","author":"Heneka","year":"2005","journal-title":"Brain"},{"key":"10.3233\/JAD-150487_ref40","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1523\/JNEUROSCI.3987-04.2004","article-title":"Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide","volume":"24","author":"Camacho","year":"2004","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-150487_ref41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress","year":"2014","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-150487_ref42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-150487_ref43","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/brain\/awu043","article-title":"Association of brain amyloid-beta with cerebral perfusion and structure in Alzheimer\u2019s disease and mild cognitive impairment","volume":"137","author":"Mattsson","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-150487_ref44","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jgs.12100","article-title":"Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: Results of a pilot randomized clinical trial","volume":"61","author":"Hajjar","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-150487_ref45","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.109.138586","article-title":"Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling","volume":"54","author":"Takeda","year":"2009","journal-title":"Hypertension"},{"key":"10.3233\/JAD-150487_ref46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","article-title":"Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"32","author":"Weber","year":"2014","journal-title":"J Hypertens"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-150487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:01Z","timestamp":1777370521000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-150487"}},"subtitle":[],"editor":[{"given":"David","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,2]]},"references-count":46,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-150487","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,2]]}}}